Rio Tinto Confirms Fully Franked USD 2.54 Final Dividend for 2025 with Updated Currency Details
Rio Tinto Confirms Fully Franked USD 2.54 Final Dividend for 2025 with Updated Currency Details

Rio Tinto Limited has updated its 2025 final dividend announcement, confirming a fully franked ordinary dividend of USD 2.54 per share payable on April 16, 2026, with detailed currency exchange rates and payment arrangements.

Pinnacle Investment Management Increases Debt Facility with CBA to $250 Million
Pinnacle Investment Management Increases Debt Facility with CBA to $250 Million

Pinnacle Investment Management Group Limited (ASX: PNI) has extended and increased its debt facility with the Commonwealth Bank of Australia from $100 million to $250 million, enhancing its financial flexibility for growth.

NSR Secures FIRB and OIO Approvals, Board Endorses Scheme Vote
NSR Secures FIRB and OIO Approvals, Board Endorses Scheme Vote

National Storage REIT (ASX:NSR) has confirmed satisfaction of key foreign investment conditions for its proposed acquisition by a Brookfield-GIC consortium, with securityholder meetings scheduled for mid-April.

Nothing to report yet...

Catch me up on the latest today

Nothing overly big yet today...

Stories making waves

Nothing to report yet...

Next moves

Our News

Mesoblast’s Ryoncil Achieves US$30.3M Q1 Sales, Nears US$100M Since Launch

Mesoblast’s Ryoncil Achieves US$30.3M Q1 Sales, Nears US$100M Since Launch

Mesoblast Limited (ASX:MSB, Nasdaq:MESO) reported net sales of US$30.3 million for its FDA-approved cellular therapy Ryoncil in the March quarter, bringing total revenue since launch close to US$100 million. Strong sales in February and March offset January’s seasonal dip.


Financials

Materials

Healthcare

Technology